| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 4 | |
| #2 | Australia | 1 | |
| #3 | Brazil | 1 | |
| #4 | Canada | 1 | |
| #5 | China | 1 | |
| #6 | EPO (European Patent Office) | 1 | |
| #7 | Hong Kong | 1 | |
| #8 | Republic of Korea | 1 | |
| #9 | Mexico | 1 | |
| #10 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Medical preparations | |
| #3 | Climate change adaptation technologies | |
| #4 | Therapeutic chemical compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Reimann Keith | 11 |
| #2 | Yu Bo | 11 |
| #3 | Wang Rijian | 11 |
| #4 | Keith Reimann | 2 |
| #5 | Bo Yu | 2 |
| #6 | Rijian Wang | 2 |
| Publication | Filing date | Title |
|---|---|---|
| EP3307322A1 | Humanized anti-cd40 antibodies and uses thereof |